Company Filing History:
Years Active: 2017-2025
Title: The Innovative Mind of Matthew McClorey in Cancer Treatment
Introduction: Matthew McClorey, a notable inventor based in Lawrence, Kansas, has made significant contributions to the field of cancer treatment through his innovative inventions. With a remarkable portfolio comprising 18 patents, McClorey is dedicated to improving therapeutic methods for patients battling cancer. His work emphasizes the integration of local and systemic delivery methods for enhanced treatment efficacy.
Latest Patents: Among his latest patents, McClorey has disclosed groundbreaking methods for cancer therapy. One of his notable patents focuses on the local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents. This innovation allows for therapeutic treatment of cancer by using a combination of local administration techniques, such as topical application, pulmonary administration, intratumoral injection, intraperitoneal injection, and intracystic injection. Another significant patent involves the treatment of epithelial cysts through the intracystic injection of antineoplastic particles, including specific taxane particles like paclitaxel and docetaxel.
Career Highlights: McClorey is currently working at Crititech, Inc., a company that specializes in innovative therapeutic solutions. His career has been marked by his commitment to advancing medical treatments, particularly through his research and development in the pharmaceutical arena. His expertise in local and systemic therapy allows for a more targeted approach in cancer treatment.
Collaborations: Throughout his career, McClorey has collaborated with several esteemed colleagues, including Michael Baltezor and Gere S diZerega. These partnerships highlight the importance of teamwork in facilitating significant advancements in medical technology.
Conclusion: Matthew McClorey stands out as a key innovator in cancer research and treatment. With a robust patent portfolio and a focus on combining local and systemic delivery methods, his work promises to contribute to a brighter future for cancer patients. His collaborations reflect a commitment to innovation in healthcare, emphasizing the importance of collaboration in the scientific community.